Global Rubella Virus Antigen Market Growth (Status and Outlook) 2025-2031

The global Rubella Virus Antigen market size is predicted to grow from US$ 114 million in 2025 to US$ 134 million in 2031; it is expected to grow at a CAGR of 2.8% from 2025 to 2031.

Rubella Virus Antigen refers to specific proteins or components of the rubella virus that are used in diagnostic tests to detect the presence of rubella virus infection in a patient. Rubella is a contagious viral infection that typically causes a mild rash and fever, but can have serious consequences when contracted by pregnant women, particularly during the first trimester, leading to birth defects or miscarriage.The Rubella Virus Antigen is often detected in laboratory tests such as enzyme-linked immunosorbent assays (ELISA) or polymerase chain reaction (PCR) methods. These antigens are primarily derived from the rubella virus’ coat proteins, which trigger an immune response in the body. During an infection, the immune system recognizes these antigens as foreign and produces antibodies against them.

United States market for Rubella Virus Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Rubella Virus Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Rubella Virus Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Rubella Virus Antigen players cover Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Rubella Virus Antigen Industry Forecast” looks at past sales and reviews total world Rubella Virus Antigen sales in 2024, providing a comprehensive analysis by region and market sector of projected Rubella Virus Antigen sales for 2025 through 2031. With Rubella Virus Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rubella Virus Antigen industry.

This Insight Report provides a comprehensive analysis of the global Rubella Virus Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rubella Virus Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rubella Virus Antigen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rubella Virus Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rubella Virus Antigen.

This report presents a comprehensive overview, market shares, and growth opportunities of Rubella Virus Antigen market by product type, application, key players and key regions and countries.

Segmentation by Type:
Rubella Protein Purity >90%
Rubella Protein Purity >95%
Rubella Protein Purity >98%
Others

Segmentation by Application:
In Vitro Diagnostics
Vaccine Development
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biomart
RayBiotech
ProSpec
Abcam
Bio-Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.